Brief: Neurogene Announces Upcoming Oral Presentation On Monitoring And Treatment To Reverse Rare Complication Of High Dose Gene Therapy
28/04/2025 22:01
April 28 (Reuters) - Neurogene Inc NGNE.O: NEUROGENE ANNOUNCES UPCOMING ORAL PRESENTATION ON MONITORING AND TREATMENT TO REVERSE RARE COMPLICATION OF HIGH DOSE GENE THERAPY AT THE ASGCT ANNUAL MEETING Source text: ID:nBw4lwJFfa Further company coverage: NGNE.O (Reuters.Briefs@thomsonreuters.com)
Recent news on Neurogene
See all newsBrief: Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Neurogene Inc reports results for the quarter ended June 30 - Earnings Summary
Neurogene Q2 adjusted loss per share misses estimates on employee costs
Neurogene Inc expected to post a loss of $1.42 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Kroger, Meta, Sable